Open AccessMaternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants
Author(s) -
Ceejay L Boyce,
Tatiana Sils,
Daisy Ko,
Annie Wong-On-Wing,
Ingrid Beck,
Sheila Styrchak,
Patricia DeMarrais,
Camlin Tierney,
Lynda StranixChibanda,
Patricia M. Flynn,
Taha E. Taha,
Maxensia Owor,
Mary Glenn Fowler,
Lisa M. Frenkel,
Impaact Bf Promoting Maternal,
Infant Survival Everywhere Study Team
Publication year - 2021
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab744
Subject(s) - breastfeeding , medicine , nevirapine , transmission (telecommunications) , viral load , drug resistance , breast feeding , hiv drug resistance , pregnancy , immunology , pediatrics , virology , virus , antiretroviral therapy , biology , genetics , microbiology and biotechnology , electrical engineering , engineering
We aimed to assess if maternal human immunodeficiency virus (HIV) drug resistance is associated with an increased risk of HIV vertical transmission and to describe the dynamics of drug resistance in HIV-infected infants.